Spironolactone for all hypertensive patients?

被引：1
|
作者：
Rosendorff, Clive [1 ,2 ]
机构：
[1] James J Peters VA Med Ctr, Bronx, NY 10468 USA
[2] Mt Sinai Sch Med, Dept Med, New York, NY USA
来源：
JOURNAL OF HYPERTENSION | 2010年 / 28卷 / 01期
关键词：
SELECTIVE ALDOSTERONE BLOCKER; BLOOD-PRESSURE; EPLERENONE;
D O I：
10.1097/HJH.0b013e328334262f
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：13 / 14
页数：2
相关论文
共 50 条
  • [31] Blood Pressure-Lowering Effect of Spironolactone in Hypertensive Patients Without Heart Failure
    Murray, Michael D.
    Tu, Wanzhu
    Li, Shanshan
    Tang, Qing
    Roberts, Anna R.
    Kippenbrock, Julie N.
    Hasty, Rachel E.
    Lynch, Sarah A.
    Hoover, Sarah A.
    Pratt, Howard
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 566 - 567
  • [32] Should a statin be given to all hypertensive patients?
    Struijker-Boudier, Harry
    ARTERY RESEARCH, 2017, 18 : 66 - 68
  • [33] Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats
    Benetos, A
    Lacolley, P
    Safar, ME
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (06) : 1152 - 1156
  • [34] The effect of melatonin in spontaneously hypertensive rats: Comparison with spironolactone
    Paulis, L.
    Krajcirovicova, K.
    Janega, P.
    Kojsova, S.
    Csizmadiova, Z.
    Pechanova, O.
    Simko, F.
    JOURNAL OF HYPERTENSION, 2007, 25 : S393 - S394
  • [35] ADEQUACY OF TWICE DAILY DOSING WITH POTASSIUM-CHLORIDE AND SPIRONOLACTONE IN THIAZIDE TREATED HYPERTENSIVE PATIENTS
    TONER, JM
    BRAWN, LA
    YEO, WW
    RAMSAY, LE
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (04) : 457 - 461
  • [36] EFFECT OF SPIRONOLACTONE ON CYTOSOLIC FREE SODIUM CONCENTRATION IN PLATELETS FROM HYPERTENSIVE PATIENTS WITH PRIMARY ALDOSTERONISM
    TEPEL, M
    HUSSEINI, S
    ZIDEK, W
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 : S51 - S52
  • [37] Atomoxetine and spironolactone combine to reduce obstructive sleep apnea severity and blood pressure in hypertensive patients
    Schwartz, Alan R.
    Herpel, Laura
    Bogan, Richard
    Corser, Bruce
    Pho, Huy
    Taranto-Montemurro, Luigi
    SLEEP AND BREATHING, 2024, 28 (06) : 2571 - 2580
  • [38] SERUM-LIPIDS AND SOME METABOLIC PARAMETERS AFTER TREATMENT WITH SPIRONOLACTONE AND THIAZIDES IN HYPERTENSIVE PATIENTS
    FAGERBERG, SE
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1982, 32 (06): : 872 - 878
  • [39] SPIRONOLACTONE DOES NOT CHANGE 24HR BP CIRCADIAN PATTERN IN RESISTANT HYPERTENSIVE PATIENTS
    Siddiqui, M.
    Jaeger, B.
    Gaddam, K.
    Dudenbostel, T.
    Judd, E.
    Pollock, D.
    Pollock, J.
    Young, M.
    Edwards, L.
    Oparil, S.
    Calhoun, D.
    JOURNAL OF HYPERTENSION, 2019, 37 : E313 - E313
  • [40] Canagliflozin and Hypertension: Is It the Optimal Choice for All Hypertensive Patients?
    Stavropoulos, Konstantinos
    Imprialos, Konstantinos P.
    Boutari, Chrysoula
    Athyros, Vasilios G.
    Karagiannis, Asterios I.
    JOURNAL OF CLINICAL HYPERTENSION, 2016, 18 (10): : 1073 - 1073
12345